Zanzonico PB - Search Results

1

Pharmacokinetics and Biodistribution of a [⁸⁹Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.

O'Donoghue JA, Danila DC, Pandit-Taskar N, Beylergil V, Cheal SM, Fleming SE, Fox JJ, Ruan S, Zanzonico PB, Ragupathi G, Lyashchenko SK, Williams SP, Scher HI, Fine BM, Humm JL, Larson SM, Morris MJ, Carrasquillo JA. O'Donoghue JA, et al. Among authors: zanzonico pb. Mol Pharm. 2019 Jul 1;16(7):3083-3090. doi: 10.1021/acs.molpharmaceut.9b00326. Epub 2019 May 31. Mol Pharm. 2019. PMID: 31117485 Free PMC article.

2

Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.

Ugur O, Kothari PJ, Finn RD, Zanzonico P, Ruan S, Guenther I, Maecke HR, Larson SM. Ugur O, et al. Nucl Med Biol. 2002 Feb;29(2):147-57. doi: 10.1016/s0969-8051(01)00290-6. Nucl Med Biol. 2002. PMID: 11823119

3

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.

Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, Riviere I, Sadelain M, O'Reilly RJ, Larson SM, Tjuvajev JG. Koehne G, et al. Nat Biotechnol. 2003 Apr;21(4):405-13. doi: 10.1038/nbt805. Epub 2003 Mar 24. Nat Biotechnol. 2003. PMID: 12652311

4

Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.

Palm S, Enmon RM Jr, Matei C, Kolbert KS, Xu S, Zanzonico PB, Finn RL, Koutcher JA, Larson SM, Sgouros G. Palm S, et al. Among authors: zanzonico pb. J Nucl Med. 2003 Jul;44(7):1148-55. J Nucl Med. 2003. PMID: 12843231 Free article.

5

Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.

Zanzonico P, O'Donoghue J, Chapman JD, Schneider R, Cai S, Larson S, Wen B, Chen Y, Finn R, Ruan S, Gerweck L, Humm J, Ling C. Zanzonico P, et al. Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):117-28. doi: 10.1007/s00259-003-1322-y. Epub 2003 Oct 2. Eur J Nucl Med Mol Imaging. 2004. PMID: 14523586

6

A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography.

Humm JL, Ballon D, Hu YC, Ruan S, Chui C, Tulipano PK, Erdi A, Koutcher J, Zakian K, Urano M, Zanzonico P, Mattis C, Dyke J, Chen Y, Harrington P, O'Donoghue JA, Ling CC. Humm JL, et al. Med Phys. 2003 Sep;30(9):2303-14. doi: 10.1118/1.1600738. Med Phys. 2003. PMID: 14528951

7

A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.

Wen B, Burgman P, Zanzonico P, O'donoghue J, Cai S, Finn R, Serganova I, Blasberg R, Gelovani J, Li GC, Ling CC. Wen B, et al. Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1530-8. doi: 10.1007/s00259-004-1673-z. Epub 2004 Sep 16. Eur J Nucl Med Mol Imaging. 2004. PMID: 15378285

8

PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.

Zanzonico PB, Finn R, Pentlow KS, Erdi Y, Beattie B, Akhurst T, Squire O, Morris M, Scher H, McCarthy T, Welch M, Larson SM, Humm JL. Zanzonico PB, et al. J Nucl Med. 2004 Nov;45(11):1966-71. J Nucl Med. 2004. PMID: 15534070 Free article. Clinical Trial.

9

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.

O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, Burnazi E, Finn RD, Burgman P, Ruan S, Lewis JS, Welch MJ, Ling CC, Humm JL. O'Donoghue JA, et al. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1493-502. doi: 10.1016/j.ijrobp.2004.12.057. Int J Radiat Oncol Biol Phys. 2005. PMID: 15817355

10

Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.

Förster GJ, Santos EB, Smith-Jones PM, Zanzonico P, Larson SM. Förster GJ, et al. J Nucl Med. 2006 Jan;47(1):140-9. J Nucl Med. 2006. PMID: 16391198 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page